An impairment in sniffing contributes to the olfactory impairment in Parkinson's disease.

نویسندگان

  • N Sobel
  • M E Thomason
  • I Stappen
  • C M Tanner
  • J W Tetrud
  • J M Bower
  • E V Sullivan
  • J D Gabrieli
چکیده

Although the presence of an olfactory impairment in Parkinson's disease (PD) has been recognized for 25 years, its cause remains unclear. Here we suggest a contributing factor to this impairment, namely, that PD impairs active sniffing of odorants. We tested 10 men and 10 women with clinically typical PD, and 20 age- and gender-matched healthy controls, in four olfactory tasks: (i) the University of Pennsylvania smell identification test; (ii and iii) detection threshold tests for the odorants vanillin and propionic acid; and (iv) a two-alternative forced-choice detection paradigm during which sniff parameters (airflow peak rate, mean rate, volume, and duration) were recorded with a pneomatotachograph-coupled spirometer. An additional experiment tested the effect of intentionally increasing sniff vigor on olfactory performance in 20 additional patients. PD patients were significantly impaired in olfactory identification (P < 0.0001) and detection (P < 0.007). As predicted, PD patients were also significantly impaired at sniffing, demonstrating significantly reduced sniff airflow rate (P < 0.01) and volume (P < 0.002). Furthermore, a patient's ability to sniff predicted his or her performance on olfactory tasks, i.e., the more poorly patients sniffed, the worse their performance on olfaction tests (P < 0.009). Finally, increasing sniff vigor improved olfactory performance in those patients whose baseline performance had been poorest (P < 0.05). These findings implicate a sniffing impairment as a component of the olfactory impairment in PD and further depict sniffing as an important component of human olfaction.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Predictors of Olfactory Impairment among Northern Iranian Population

Introduction: The performance in most smell identification tests is subjected to cultural variations. This study aimed to evaluate age, gender, and smoking-related effects on the test performance in the North of Iran.   Materials and Methods: The olfactory function of 1470 eligible subjects was assessed in this study. Moreover, this study evaluated the influence of age, ...

متن کامل

Olfactory Loss in Parkinson's Disease

Impairment of olfaction is a characteristic and early feature of Parkinson's disease. Recent data indicate that >95% of patients with Parkinson's disease present with significant olfactory loss. Deficits in the sense of smell may precede clinical motor symptoms by years and can be used to assess the risk for developing Parkinson's disease in otherwise asymptomatic individuals. This paper summar...

متن کامل

بررسی میزان ناتوانی‌های بیماران پارکینسونی در بخش مغز و اعصاب بیمارستان شهدای عشایر و کلینیک های مغز و اعصاب خصوصی شهر خرم آباد در نیمه اول سال 1389

Background : Parkinson's disease (PD) is a progressive degenerative disorder with multiple motor and non motor symptoms. These features can cause disability and extensive dysfunction in patients. This study is conducted to evaluate the disabilities of PD patients. Materials and Methods: The study was case series. Depression, cognitive impairment and disability of patients were diagnosed based ...

متن کامل

The reversal effect of mefenamic acid in the sporadic model of Alzheimer's disease in rat: a behavioral analysis

Alzheimer’s disease (AD) is a chronic neurodegenerative disease causing progressive impairment of memory and cognitive function. Streptozotocin (STZ) injection into the brain is known to cause cognitive impairment in rats and is similar to sporadic AD in humans. Several lines of evidence have indicated that an inflammatory process contributes to the pathology of AD. On the basis of the results ...

متن کامل

The reversal effect of mefenamic acid in the sporadic model of Alzheimer's disease in rat: a behavioral analysis

Alzheimer’s disease (AD) is a chronic neurodegenerative disease causing progressive impairment of memory and cognitive function. Streptozotocin (STZ) injection into the brain is known to cause cognitive impairment in rats and is similar to sporadic AD in humans. Several lines of evidence have indicated that an inflammatory process contributes to the pathology of AD. On the basis of the results ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Proceedings of the National Academy of Sciences of the United States of America

دوره 98 7  شماره 

صفحات  -

تاریخ انتشار 2001